Article
RIPPLY1 suppresses cancer cell stemness via targeting TBX19 in CTNNB1 -mutated hepatocellular carcinoma.
Hepatology (Baltimore, Md.) - 1 Jul 2026
Zhangyuan Guangyan, Yu Weiwei, Tian Wenfang, Xie Junjie, Wang Jun, Ying Xiayang, Wang Fei, Shao Yufei, Tan Xiuxiang, Qian Hao, Deng Yexuan, Shen Baiyong
Abstract excerpt
BACKGROUND AND AIMS: CTNNB1 -mutated HCCs exhibit a relatively low stem-like and well-differentiated phenotype. However, the mechanism remains unclear. Ripply transcriptional repressor 1 (RIPPLY1), a transcriptional repressor required for somite segmentation, has hardly been studied in cancer. Here, we aim to unveil the role of RIPPLY1 in the regulation of cancer cell stemness in CTNNB1 -mutated HCCs. APPROACH...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
